UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment

Hepatology (Baltimore, Md.), 2017-05, Vol.65 (5), p.1438-1450

2017

Volltextzugriff (PDF)

Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice

Hepatology international, 2021-10, Vol.15 (5), p.1122-1135

2021

Volltextzugriff (PDF)

Systematic review and meta-analysis: Significant histological changes among treatment-naïve chronic hepatitis B patients with normal alanine aminotransferase levels by different criteria

Alimentary pharmacology & therapeutics, 2023-10

2023

Volltextzugriff (PDF)

Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis

Journal of hepatology, 2022-12, Vol.77 (6), p.1564-1572

2022

Volltextzugriff (PDF)

Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial

The American journal of gastroenterology, 2024-04, Vol.119 (4), p.700-711

2024

Volltextzugriff (PDF)

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets

BMJ open gastroenterology, 2016-01, Vol.3 (1), p.e000079-e000079

2016

Volltextzugriff (PDF)

The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease

Journal of hepatology, 2021-08, Vol.75 (2), p.454-461

2021

Volltextzugriff (PDF)

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double‐blind trial

Hepatology (Baltimore, Md.), 2008-02, Vol.47 (2), p.447-454

2008

Volltextzugriff (PDF)

ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice

Gastroenterology (New York, N.Y. 1943), 2019-11, Vol.157 (5), p.1352-1367.e13

2019

Volltextzugriff (PDF)

DENND3 p.L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway

Hepatology international, 2023-06, Vol.17 (3), p.648-661

2023

Volltextzugriff (PDF)

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Gut, 2016-02, Vol.65 (2), p.313-320

2016

Volltextzugriff (PDF)

Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis

JHEP reports, 2024-07, Vol.6 (7), p.101091, Article 101091

2024

Volltextzugriff (PDF)

Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis

Hepatology international, 2021-12, Vol.15 (6), p.1318-1327

2021

Volltextzugriff (PDF)

Chinese guidelines on the management of ascites in cirrhosis: Chinese Society of Hepatology, Chinese Medical Association

Hepatology international, 2024-08, Vol.18 (4), p.1071-1089

2024

Volltextzugriff (PDF)

A prospective study on the differential association of sarcopenia and frailty with health outcomes in cirrhotic patients

Digestive and liver disease, 2023-11, Vol.55 (11), p.1533-1542

2023

Volltextzugriff (PDF)

Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis

Hepatology international, 2023-12, Vol.17 (6), p.1350-1358

2023

Volltextzugriff (PDF)

Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy

Hepatology international, 2021-02, Vol.15 (1), p.82-92

2021

Volltextzugriff (PDF)

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

Journal of clinical and translational hepatology, 2023-11, Vol.11 (6), p.1425-1442

2023

Volltextzugriff (PDF)

Consensus on the secondary prevention of primary liver cancer

Hepatology international, 2021-12, Vol.15 (6), p.1289-1300

2021

Volltextzugriff (PDF)

Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha

Clinical gastroenterology and hepatology, 2020-01, Vol.18 (1), p.196-204.e8

2020

Volltextzugriff (PDF)

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B

Hepatology research, 2018-02, Vol.48 (3), p.E213-E221

2018

Volltextzugriff (PDF)

Consensus on the tertiary prevention of primary liver cancer

Hepatology international, 2023-10, Vol.17 (5), p.1057-1071

2023

Volltextzugriff (PDF)

Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events

Clinical gastroenterology and hepatology, 2024-03, Vol.22 (3), p.591-601.e3

2024

Volltextzugriff (PDF)

Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?

Journal of gastroenterology and hepatology, 2022-03, Vol.37 (3), p.471-479

2022

Volltextzugriff (PDF)

Chinese guidelines on the management of ascites and its related complications in cirrhosis

Hepatology international, 2019-01, Vol.13 (1), p.1-21

2019

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

ThemaGastroenterology & Hepatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment

Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice

Systematic review and meta-analysis: Significant histological changes among treatment-naïve chronic hepatitis B patients with normal alanine aminotransferase levels by different criteria

Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis

Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets

The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double‐blind trial

ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice

DENND3 p.L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis

Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis

Chinese guidelines on the management of ascites in cirrhosis: Chinese Society of Hepatology, Chinese Medical Association

A prospective study on the differential association of sarcopenia and frailty with health outcomes in cirrhotic patients

Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis

Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

Consensus on the secondary prevention of primary liver cancer

Variants in STAT4 Associated With Cure of Chronic HBV Infection in HBeAg-positive Patients Treated With Pegylated Interferon-alpha

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B

Consensus on the tertiary prevention of primary liver cancer

Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events

Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?

Chinese guidelines on the management of ascites and its related complications in cirrhosis

Aktive Filter

Suchergebnisse filtern